*UPDATE: As of May 2018, juries had awarded more than $900 million to people who blamed talcum powder use for causing cancer. People who developed ovarian cancer or mesothelioma cancer after talcum powder exposure continue to file lawsuits. Drugwatch’s legal partners are accepting new cases.

People are filing lawsuits against talc manufacturers over claims that talc exposure led to mesothelioma or ovarian cancer.

Juries have found companies knew or should have known about talc’s risks. But companies did little or nothing to warn consumers about the dangers of their products.

Companies named in lawsuits include Johnson & Johnson, Vanderbilt Minerals and Colgate-Palmolive.

So far, juries have returned millions of dollars in verdicts for plaintiffs.

Drugwatch’s legal partners are accepting talcum powder mesothelioma cases because of industrial and cosmetic talcum powder use.

As of April 2018, juries have awarded more than $153 million in talcum powder mesothelioma claims.

Two talc mesothelioma lawsuits went to trial in February 2018.

Stephen Lanzo III was the most recent plaintiff to go to trial. In April 2018, a New Jersey jury awarded Lanzo and his wife $117 million.

The lawsuit claimed Lanzo developed mesothelioma after using Johnson & Johnson’s talcum powder products. He used baby powder and Shower to Shower.

In March 2018, Vanderbilt Minerals reached a confidential settlement with Robert Lord in a Florida court. Lord worked with Vanderbilt’s industrial talcum powder at a tile company in the 1970s and developed mesothelioma.

Drugwatch’s legal partners are currently accepting talcum powder ovarian cancer cases from talcum powder use.

As of June 2018, there were 8,436 lawsuits pending in a multidistrict litigation (MDL) in New Jersey federal court. Johnson & Johnson and talc supplier Imerys Talc are the defendants in the MDL.

By late-2017, juries had awarded more than $700 million in verdicts against talc manufacturers.

Courts in New Jersey, Missouri and California also consolidated several talc ovarian cancer lawsuits.

The federal MDL is still in the early stages and none of those cases have made it to trial yet. Most of the verdicts have come in Missouri and California.

There are two types of talcum powder cancer claims: personal injury claims and wrongful death claims.

Lawyers file personal injury lawsuits claims on behalf of people who were diagnosed with mesothelioma or ovarian cancer after exposure to talc.

Because mesothelioma and ovarian cancers are often fatal, sometimes a person may die before they can file a claim. If this happens, lawyers can file wrongful death lawsuits for surviving family members.

Each of these types of lawsuits has its own time limit to file. This is called a statute of limitations.

The statute of limitations is the time limit people have to file a lawsuit. If people wait too long to file a lawsuit, they may be forever barred from doing so. The exact time limit varies depending on individual state laws.

For talcum powder mesothelioma and ovarian cancer claims, the clock starts ticking after the cancer diagnosis. Most states have a two- or three-year statute of limitations.

Families can still file lawsuits if a loved one died of talcum powder cancer. In wrongful death claims, the clock starts ticking from the date of death. Most states have a two- or three-year statute of limitations.

People filed lawsuits against makers of major brands of talcum powder products. They also sued mining companies that supply these manufacturers with raw talc.

Juries have awarded more than $700 million to women who have sued claiming they developed ovarian cancer after routinely using talcum powder. Juries have also awarded more than $36 million to people who developed mesothelioma after using talcum powder or being exposed to industrial talc.

Most settlements so far have been with individual plaintiffs and have been for undisclosed amounts.

There have been at least four class action lawsuits filed over talc-related products and possible cancer risk. Two have been dismissed or absorbed into other cases.